Headlines

62 million. That’s how many vehicles were recalled by automakers in the United States in 2014. To put that in perspective, that’s about one car for every five on the road. And while GM holds a significant stake in that total with more than 80 separate recalls affecting close to 27 million automobiles just in North…

The New York Times reports that medical device manufacturer Johnson & Johnson continued to market artificial hip implants abroad after the FDA prohibited the sale of these devices in the United States.

On Friday, Jan. 20, 2012, a U.S. congressional committee was again asked to further "examine medical devices that have developed serious defects after being implanted in patients."

In a recent article that ran in Lawyers Weekly USA, Motley Rice medical attorney Fidelma Fitzpatrick was interviewed about the first case to go to trial involving a pelvic mesh/transvaginal mesh product.

On Feb. 25, 2013, after five days of deliberation, a New Jersey jury awarded $3.5 million in compensatory damages to the plaintiffs in a transvaginal/pelvic mesh lawsuit against pharmaceutical giant Johnson & Johnson.

A recent, alarming article by Bloomberg suggests that C.R. Bard’s (BCR) Davol unit knew that the plastic it used in its Avaulta line of transvaginal (pelvic) mesh devices was unsafe to be permanently implanted in humans.

Motley Rice has reached an Agreement in Principle to settle with transvaginal mesh (TVM) device manufacturer American Medical Systems, Inc. (AMS) and parent company Endo International plc.

It is estimated that more than two million women in the United States have used the Mirena IUD device in the past ten years.

Attorney Carmen Scott urges women to learn the facts about contraceptives, and to speak with a physician about the pros and cons associated with various kinds of hormonal contraceptives.

In the significant <em> Lance v. Wyeth</em> decision, the Pennsylvania Supreme Court rejected Wyeth Ltd.’s argument that it was untouchable for injuries to users of its now discontinued weight loss drug, Redux.